Full-Time

Senior Manager

Analytical Development and Quality Control

Posted on 11/27/2024

Pliant Therapeutics

Pliant Therapeutics

51-200 employees

Develops treatments for fibrotic diseases

Biotechnology
Healthcare

Compensation Overview

$160k - $170kAnnually

Senior

San Bruno, CA, USA

Hybrid position requiring 3 days/week at Pliant in South San Francisco.

Category
Biology Lab & Research
Biology & Biotech
Requirements
  • B.S. in Chemistry or relevant technical field, advanced degree preferred.
  • A minimum of 8 years’ experience in analytical development of new chemical entities in the pharmaceutical industry including managing methods development, validation, and testing at contract testing laboratories.
  • Must have hands-on experience with analytical development techniques used in pharmaceutical industry including LC, LC-MS, GC, and Dissolution.
  • Comprehensive working knowledge of GLPs and GMPs as they relate to drug development and analytical testing.
  • Excellent written and verbal communication skills and organizational skills as well as ability to prioritize and manage multiple tasks under tight timelines.
  • Ability to engage collaboratively with CMC functions, with other functions within Pliant, and with external testing laboratories.
Responsibilities
  • Manage the development, qualification/validation, and transfer of analytical methods at contract laboratories. Review analytical data from contract partners, provide feedback and facilitate resolution of technical or quality issues.
  • Manage CMOs/CROs testing labs for all analytical development and quality control activities
  • Assist in selection and management of contract laboratories.
  • Collaborate with other members of CMC team to ensure timely release of clinical products and resolution of product investigations.
  • Author and review technical reports, deviations, and change control documents.
  • Summarize experimental findings, review, and interpret development and stability study results, and assemble analytical data packages to support regulatory submissions.
  • Manage sample inventory and support miscellaneous activities, such as shipping etc.

Pliant Therapeutics develops treatments for fibrotic diseases, which cause thickening and scarring of connective tissue, leading to organ dysfunction. Their products work by targeting the biological mechanisms behind fibrosis, particularly through the inhibition of integrins, proteins that help cells stick together and communicate. This focus allows Pliant to create specific and effective therapies for various fibrotic conditions. Unlike many competitors, Pliant emphasizes a deep understanding of fibrosis and integrin biology, which informs their drug development process. The company's goal is to stop the progression of fibrotic diseases and restore normal organ function, ultimately improving the lives of patients affected by these conditions.

Company Stage

IPO

Total Funding

$201.4M

Headquarters

San Francisco, California

Founded

2015

Growth & Insights
Headcount

6 month growth

0%

1 year growth

7%

2 year growth

47%
Simplify Jobs

Simplify's Take

What believers are saying

  • Positive Phase 2a trial data for bexotegrast in PSC supports further development.
  • Growing interest in integrin-targeting therapies aligns with Pliant's strategic focus.
  • FDA's supportive regulatory environment accelerates fibrosis treatment development.

What critics are saying

  • Intensifying competition in IPF treatments may impact Pliant's market share.
  • FDA scrutiny on accelerated approval pathways could delay drug approvals.
  • Volatility in biotech stock markets may affect Pliant's capital-raising efforts.

What makes Pliant Therapeutics unique

  • Pliant focuses on integrin-targeting therapies for fibrotic diseases, a unique approach.
  • PLN-74809 has Orphan Drug Designation for IPF and PSC, enhancing its market potential.
  • Partnership with Novartis for PLN-1474 strengthens Pliant's position in liver fibrosis treatment.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE